Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) on Thursday posted fourth-quarter earnings that missed forecasts and said that it expects its reported figures this year will be lower than previously anticipated due to exchange rates against ... more»

(Bloomberg) -- The obsession with holding kroner that has gripped speculators since mid-January is hard to explain given the state of Denmark's economy. That's according to the Organization for Economic Cooperation and Development. “It's actually ... more»